Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2009. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary shares by several executives on May 12, 2009, at a price of £10.48 per share through the Company's Share Reward Plan. The transactions involved both personal contributions (partnership element) and company contributions (matching element). Specific acquisitions included:
- Mr. A P Witty: 11 shares (personal) and 11 shares (company match).
- Mr. J S Heslop: 11 shares (personal) and 11 shares (company match).
- Mr. S M Bicknell: 11 shares (personal) and 11 shares (company match).
- Mr. E J Gray: 11 shares (personal) and 11 shares (company match).
- Mr. S A Hussain: 12 shares (personal) and 12 shares (company match).
- Mr. D Learmouth: 11 shares (personal) and 11 shares (company match).
- Mr. D S Redfern: 11 shares (personal) and 11 shares (company match).
- Ms. C Thomas: 11 shares (personal) and 11 shares (company match).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transactions described above in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Investor Verification Points
- Verify the share price of £10.48 per Ordinary share on May 12, 2009.
- Confirm the total number of shares acquired by each listed executive under the Share Reward Plan.
- Review the terms of the Company's Share Reward Plan to understand the matching contribution structure.
- Check subsequent filings for any changes in the holdings of these directors.